These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 5342479)
1. [Method of determination of the clinical effectiveness of coronary vasodilators]. Ushiyama K Nihon Rinsho; 1966 Nov; 24(11):2149-55. PubMed ID: 5342479 [No Abstract] [Full Text] [Related]
2. [Importance of the placebo in the clinical evaluation of so-called coronary vasodilator agents in patients with clinical manifestations of angina pectoris]. Calandre L; Ruano JM Rev Esp Cardiol; 1965 Apr; 18(2):168-72. PubMed ID: 5319557 [No Abstract] [Full Text] [Related]
3. [Lidoflazine in angina pectoris. I. Double blind study]. Batlouni M; Betolami V; Duprat R Arq Bras Cardiol; 1968 Oct; 21(5):321-6. PubMed ID: 4886984 [No Abstract] [Full Text] [Related]
4. Investigation of verapamil in the treatment of angina pectoris. Sandler G Brux Med; 1970 Sep; 50(9):669-73. PubMed ID: 4928626 [No Abstract] [Full Text] [Related]
5. [Ethical problems in antiangina drug experimentation]. Vastesaerger M Brux Med; 1970 Sep; 50(9):675-6. PubMed ID: 4928627 [No Abstract] [Full Text] [Related]
6. [Verapamil in the treatment of angina pectoris. Comparative double-blind study with fendilin]. Albuquerque DC; Schlesinger P; Benchimol CB; Albanesi FM; Benchimol AB Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():63-7. PubMed ID: 354613 [No Abstract] [Full Text] [Related]
7. [Double-blind clinical trial of a new coronary-active drug, MD 6753]. Dalla Volta S Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049 [No Abstract] [Full Text] [Related]
8. [The effect of five different long-acting nitroglycerine derivatives on angina pectoris]. Kaltenbach M; Tiedemann I; Schellhorn W Dtsch Med Wochenschr; 1972 Oct; 97(40):1479-84. PubMed ID: 4627249 [No Abstract] [Full Text] [Related]
9. The clinical effect of 4-(2'-nitrophenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine (BAY a 1040) on angina pectoris evaluated by sequential analysis. Kimura E; Mabuchi G; Kikuchi H Arzneimittelforschung; 1972 Feb; 22(2):365-7. PubMed ID: 4623700 [No Abstract] [Full Text] [Related]
10. Proceedings: A comparative study of perhexiline, beta-adrenergic blocking agents and placebos in the management of angina pectoris. Armstrong ML Postgrad Med J; 1973 Apr; 49():Suppl 3:108-12. PubMed ID: 4587026 [No Abstract] [Full Text] [Related]
11. Therapy of angina pectoris with propranolol and long-acting nitrates. Goldbarg AN; Moran JF; Butterfield TK; Nemickas R; Bermudez GA Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4988122 [No Abstract] [Full Text] [Related]
12. [Clinical trials of anti-angina drugs]. Camerini E; Alberti E; Borgioni L; Medugno G; Scardi S G Ital Cardiol; 1976; 6(7):1291-304. PubMed ID: 13024 [No Abstract] [Full Text] [Related]
13. Iproveratril--a new coronary dilator. Misra SS; Sircar AR J Indian Med Assoc; 1967 Feb; 48(4):163-6. PubMed ID: 5342284 [No Abstract] [Full Text] [Related]
14. [Use of multicenter clinical trial of molsidomine by single-blind method in stable angina pectoris]. Jasiński K; Lukasik S; Poprawski K; Wrabec K; Nowosad H; Kargul W Kardiol Pol; 1981; 24(5):397-405. PubMed ID: 7021947 [No Abstract] [Full Text] [Related]
15. Trimetazidine in the treatment of angina pectoris. Brodbin P; O'Connor CA Br J Clin Pract; 1968 Sep; 22(9):395-6. PubMed ID: 4970482 [No Abstract] [Full Text] [Related]
16. Perhexiline maleate in the treatment of angina pectoris. Hirshleifer I Curr Ther Res Clin Exp; 1969 Mar; 11(3):99-105. PubMed ID: 4975919 [No Abstract] [Full Text] [Related]